Compare with Merck & Company, Inc.



Key facts today


Merck began enrolling patients in a Phase 3 trial of OHTUVAYRE plus standard care to prevent COPD flare-ups. The study targets 2,136 adults across 28 countries and will track outcomes for 52 weeks. 1 2
Freedom Broker maintained its Hold rating on Merck & Co., Inc. (MRK) and raised its price target to $140 from $125. 1
Analyze the impactAnalyze the impact
Market capitalization
‪368.89 B‬ USDMega cap
‪18.25 B‬ USD
‪64.93 B‬ USD
‪2.46 B‬
Beta (1Y)
−0.32
Last report date
—
Report period
—
EPS
—
Revenue
—
Earnings release details

Q3 revenue rose 5% to $18.1B, with new products and oncology and animal health strength. 2026 guidance midpoint increased; 2027 is expected to bring moderate growth amid >$2B of generic and LOE headwinds and continued investment.

Employees (FY)
‪75 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪865.68 K‬ USD
Net income / Employee (1Y)
‪243.39 K‬ USD

Company info


CEO
Robert M. Davis
Website
Headquarters
Rahway
Founded
1891
IPO date
Jan 1, 1941
ISIN
US58933Y1055
CUSIP
58933Y105
FIGI
BBG000BPD168
Identifiers
ISIN US58933Y1055
CFI code
ESVUFR
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
Neutral
Neutral
An aggregate view of professional's ratings.
Neutral
Neutral
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.
Maturity dateFeb 20, 2035
Coupon2.88% (Fixed)
Maturity dateJul 13, 2027
Coupon4.30% (Fixed)
Maturity dateJun 16, 2031
Coupon4.60% (Fixed)
Maturity dateFeb 3, 2032
Coupon2.88% (Variable)
Maturity dateMay 24, 2028
Coupon3.40% (Fixed)
Maturity dateSep 28, 2027
Coupon0.88% (Fixed)
Maturity dateJan 18, 2028
Coupon3.70% (Fixed)
Maturity dateJan 12, 2029
Coupon3.50% (Fixed)
Maturity dateJul 8, 2030
Coupon2.76% (Fixed)
Maturity dateJan 26, 2031
Coupon2.95% (Fixed)

See all MRK bonds 

Weight0.49%
Market value‪11.38 B‬
Weight0.54%
Market value‪9.42 B‬
Weight0.56%
Market value‪4.88 B‬
Weight3.80%
Market value‪4.61 B‬
Weight0.56%
Market value‪4.49 B‬
Weight1.36%
Market value‪3.41 B‬
Weight5.47%
Market value‪2.68 B‬
Weight1.59%
Market value‪2.03 B‬
Weight1.53%
Market value‪1.46 B‬
Weight5.01%
Market value‪1.10 B‬
Weight0.56%
Market value‪1.02 B‬

Explore more ETFs 

Frequently asked questions


Merck & Company, Inc. is scheduled to release its next earnings report on Feb 2, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
MRK stock is 3.41% volatile and has beta coefficient of −0.32.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like MRK are typically less volatile than smaller companies

Track every detail on Merck & Company, Inc. stock chart and check out the list of the most volatile stocks — is Merck & Company, Inc. there?
To understand the MRK stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −0.78%
– 1 week — +1.69%
– 1 month — +3.19%

MRK all-time low was 0.27 USD (Jun 25, 1962), and its highest price is 156.92 USD (Aug 25, 2026). Find more dynamics in the Stock Heatmap and on the Merck & Company, Inc. stock chart.
Merck & Company, Inc. market capitalization is ‪366.03 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from Merck & Company, Inc. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how Merck & Company, Inc. stacks up against other companies
The safest way to buy Merck & Company, Inc. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade MRK directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 4, 2026, the company has ‪75 K‬ employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Merck & Company, Inc. pays dividends, but whether it is a “good” dividend stock depends on its yield and stability rather than dividends alone.

Its recent dividend yield was around 3.12%, with a payout ratio of 45.05%, compared to 3.14% and 46.32% in the previous period.

What to look at when looking for good dividend stocks:
– Dividend yield: Income potential relative to price
– Payout ratio: Sustainability of dividend payments
– Dividend history: Consistency and growth over time
– Earnings strength: Dividends are more reliable when supported by stable profits
– Total return: Combines dividends with stock price performance

Explore all this in Merck & Company, Inc. financials.
Investing in Merck & Company, Inc. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study Merck & Company, Inc. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our MRK technicals – signals based on essential indicators calculations:
– Today — neutral
– 1-week — buy
– 1-month — buy

Combine fundamental and technical analysis for better results.
Merck & Company, Inc. stock ticker depends on the exchange where it’s listed. On the NYSE, its primary exchange, Merck & Company, Inc. stocks trade under the symbol MRK.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
MRK earnings for the last quarter are 2.49 USD per share, whereas the estimation was 2.09 USD, resulting in a 19.40% surprise. The estimated earnings for the next quarter are 1.77 USD per share.

How to read financials:
– Compare actual vs estimates: Earnings beats or misses often drive price moves
– Watch market reaction: Price response matters as much as the numbers
– Look at forward guidance: Future estimates signal expected growth
– Track trends: Analyze results across multiple quarters, not just one

Follow other essential metrics in Merck & Company, Inc. financials:
– Revenue growth: Shows business expansion
– Margins (operating, net): Reflect profitability and efficiency
– Free cash flow: Indicates real cash generation
– Debt levels: Impacts financial stability and risk
Merck & Company, Inc. revenue for the last quarter amounts to ‪18.09 B‬ USD despite the estimated figure of ‪17.33 B‬ USD. In the next quarter revenue is expected to reach ‪16.32 B‬ USD.

How to read this data:
– Compare actual vs estimates: Revenue beats or misses can move the stock
– Watch market reaction: Price response shows how investors interpret results
– Look at growth: Compare with previous quarters and year-over-year data
– Track trends: One quarter matters less than consistent performance

Follow other essential metrics in Merck & Company, Inc. financials:
– Earnings (EPS): Profitability per share
– Margins (gross, operating): Efficiency and cost control
– Free cash flow: Cash available after expenses
Yes, you can track Merck & Company, Inc. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
MRK net income for the last quarter is ‪5.07 B‬ USD, while the quarter before that showed ‪−1.33 B‬ USD of net income which accounts for 479.40% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in Merck & Company, Inc. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
Merck & Company, Inc. does pay dividends, which are distributed quarterly. The most recent dividend per share was 0.85 USD, with a trailing twelve-month (TTM) dividend yield of 2.29%.

Explore more details on Merck & Company, Inc. dividends, look at:
– Dividend history: Check whether payouts are growing, stable, or declining
– Payout ratio: How much of earnings are paid out as dividends
– Total return: Combine price growth + dividends for full performance view
MRK reached its all-time high of 156.92 USD on Aug 25, 2026. Its all-time low was 0.27 USD and was reached on Jun 25, 1962.

Explore the Merck & Company, Inc. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
Analyst forecasts suggest a price range between 105.00 USD and 186.00 USD for MRK, based on current estimates.

Remember:
– Forecasts show possible scenarios, not guaranteed outcomes
– They're based on multiple analysts’ models and assumptions
– Target prices change with earnings, news, and market conditions

Don't rely on analysts' opinions alone:
– Use technical analysis: Trend, support/resistance, momentum
– Study fundamentals: Revenue, earnings, margins
– Account for market context: News, macro trends, sector performance